Choosing STAQ Pharma means opting for a partner dedicated to the highest standards of quality and safety in outsourced medication. Founded with the vision to address a critical need in the healthcare industry, STAQ Pharma has set itself apart by constructing two state-of-the-art 503B Outsourcing Facilities that adhere to cGMP standards from the ground up. Our unique partnership model with hospitals ensures we meet the precise needs of healthcare providers, offering medications that are safe and effective.

Long Grove Pharmaceuticals is an experienced and innovative pharmaceutical company focused on complex generics and proprietary 505(b)(2)s. Long Grove has a heritage of proven success with in-house research and development from our parent company, Capstone Development Services.

Long Grove approaches the generic pharmaceutical market with innovative People, Products and Processes. Our innovative approach includes:

With a steadfast commitment to improving patient lives, Cipla USA has been a key player in the pharmaceutical industry for over 30 years. Our focus on affordability and quality has allowed us to facilitate access to a diverse range of pharmaceutical products tailored for the acute care space and clinics. Our dedication to oncology is evident through the introduction of pioneering 505(b)(2) oncology products, aligning seamlessly with our overarching 'Caring for Life' mission.

Techdow USA develops, manufactures, and sells critical FDA approved products. We can deliver hard to source products at a competitive price.

Slayback is a New Jersey-based company focused on complex generic and specialty pharmaceutical products with a team in the U.S., India and Europe.